The Comparison of the Efficacy and Safety of Arzoxifene versus Raloxifene in Postmenopausal Women with Osteoporosis

Mise à jour : Il y a 5 ans
Référence : EUCTR2006-001987-22

Femme Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

The primary objective of this study is to compare the effect of orally administered 20 mg arzoxifene daily versus orally administered 60 mg raloxifene daily on 12-month percent change from baseline in lumbar spine BMD in postmenopausal women with osteoporosis, as assessed by dual energy x-ray absorptiometry DXA .


Critère d'inclusion

  • Prevention and treatment of osteoporosis